Showing results (131-140 of 181) with videos related to
Sort By:
Pageof 19
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2024
The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosisQingtian Zhu, Chenchen Yuan, Dan Wang, et al.Cell Reports. Medicine|November 30, 2023
Bile acid metabolomics identifies chenodeoxycholic acid as a therapeutic agent for pancreatic necrosisQingtian Zhu, Chenchen Yuan, Xiaowu Dong, et al.International Journal of Molecular Sciences|May 27, 2026
Targeted Metabolomics Uncovers NorCA's Role as a Potent Immunomodulator in Acute Pancreatitis by Promoting Macrophage Reprogramming and EfferocytosisLingju Chu, Lei Zhang, Xinyi Liu, et al.European Journal of Medicinal Chemistry|May 31, 2022
Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degraderCheng-Liang Zhu, Xiaomin Luo, Tian Tian, et al.Gastroenterology Research and Practice|August 2, 2021
The Diagnosis and Treatment of Local Complications of Acute Necrotizing Pancreatitis in China: A National SurveyXiaowu Dong, Wenjian Mao, Lu Ke, et al.European Journal of Medicinal Chemistry|June 15, 2024
Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AMLMingfei Wu, Wei Wang, Xinfei Mao, et al.Journal of Ethnopharmacology|July 22, 2023
Chaiqin chengqi decoction alleviates acute pancreatitis by targeting gasdermin D-mediated pyroptosisFei Cao, Jie Xiang, Yaodong Wang, et al.Theranostics|July 9, 2019
GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer ImagingRuiying Guo, Feng Huang, Bo Zhang, et al.Advanced Materials (Deerfield Beach, Fla.)|November 21, 2024
An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor ImmunityYuejun Yao, Mingfei Wu, Yanfang Wang, et al.European Journal of Medicinal Chemistry|July 18, 2020
Structure-based design, synthesis and bioactivity evaluation of macrocyclic inhibitors of mutant isocitrate dehydrogenase 2 (IDH2) displaying activity in acute myeloid leukemia cellsJinxin Che, Feng Huang, Mengmeng Zhang, et al.Pageof 19